Malta offers to provide 60 mn Sputnik V doses

Tribune News Service

Chandigarh, June 6

Pharma Regulatory Services Limited, headquartered in Malta, has given an Expression of Interest to Haryana Medical Services Corporation (HMSCL) to provide up to 60 million doses of Sputnik-V vaccine manufactured by Gamaleya Institute and Russian Direct Investment Fund (RDIF).

Sputnik V is one of the three vaccines currently approved by DCGI for use in India.

As per the offer made by the firm, the per dose cost of the vaccine will nearly be Rs 1,120. The firm has further given a timeline of 30 days to supply the first batch of 5,00,000 followed by 1 million doses every 20 days till the supply is completed against a letter of credit issued in their name.

Haryana had floated a global tender for vaccines through HMSCL on May 26 which closed on June 4.

Additional Chief Secretary, Health, Rajeev Arora said that though the offer has come after the due date of the tender is over, it is being carefully examined to see if it meets the criteria of the tender document and to ensure optimal vaccine availability for the state.

Health Minister Anil Vij has shared that the state has received a proposal for supply of 30 million dose-1 and 30 million dose-2 from Pharma Regulatory Services Limited, Malta.

Vij tweeted today that the state government was considering this proposal and would present it in the Cabinet meeting for final approval.